/
OUR BUSINESS KORU Medical develops, manufactures and commercializes innovative and patient-centric large volume subcutaneous infusion solutions primarily for the subcutaneous drug delivery market as governed by the United States Food and Drug Administration (the FDA ) quality and regulatory system and international standards for quality system management. Our focus is primarily concentrated on …
The business is unprofitable at the operating level (-7.23% margin). The thesis depends entirely on whether and when it reaches sustainable profitability.
Revenue up 22.2% YoY with margins expanding 11.9pp.
Negative free cash flow of -$470K. The business is consuming cash, not generating it.
Profitability & Returns
Revenue (TTM)
$43M
▲ +22.2% YoY
Net Income (TTM)
-$2M
▲ +56.5% YoY
Op. Margin
-5.99%
▲ +11.9pp YoY
ROIC
-10.12%
▲ +11.0pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
$179K
▲ +70.9% YoY
Op. Cash Flow (TTM)
$715K
▲ +244.6% YoY
Net Debt
-$5M
Net Cash Position
Cash & Equiv.
$9M
5Y CAGR: +11.2%
Continue Research